Work

Efficacy and Safety of Bosutinib Versus Imatinib in US Patients with Newly Diagnosed Chronic Myeloid Leukemia after 5-Years Follow-up in the Bfore Trial

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-162428

Authors: Vamsi K. Kota, Michael W. Deininger, Jason H. Mendler, Wei Shen, Erinn Hoag Goldman, Jorge E. Cortes

Institutions: Augusta University, Augusta University Health, University of Rochester Medicine, Pfizer (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310124587

FWCI: 0.156

Cites:

Cited by: 1

Related to: 10